MDR-TB Risk Assessment: Identifies patients requiring rapid molecular resistance testing. Drug-susceptibility testing (DST) is gold standard.
Management Recommendation
Standard TB workup recommended. Drug resistance is unlikely but clinical monitoring continues.
Verified
Last Review: 2026
Last Comprehensive Review: 2026